Calidi Biotherapeutics (Calidi Biotherapeutics) Current Accrued Expense : $3.29 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Current Accrued Expense?

Calidi Biotherapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was $3.29 Mil.

Calidi Biotherapeutics's quarterly Current Accrued Expense increased from Sep. 2023 ($2.97 Mil) to Dec. 2023 ($5.43 Mil) but then declined from Dec. 2023 ($5.43 Mil) to Mar. 2024 ($3.29 Mil).

Calidi Biotherapeutics's annual Current Accrued Expense increased from Dec. 2021 ($3.51 Mil) to Dec. 2022 ($5.35 Mil) and increased from Dec. 2022 ($5.35 Mil) to Dec. 2023 ($5.43 Mil).

Calidi Biotherapeutics Current Accrued Expense Historical Data

The historical data trend for Calidi Biotherapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Current Accrued Expense Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

1.54

3.51

5.35

5.43

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial					-	6.90	2.97	5.43	3.29

Calidi Biotherapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Calidi Biotherapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024